H.C. Wainwright downgraded Asensus Surgical to Neutral from Buy with a price target of 35c, down from $2, after the company entered into a letter of intent with Karl Storz that includes a proposal to be acquired for a purchase price of 35c per share in cash.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASXC:
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
- Options Volatility and Implied Earnings Moves Today, March 21, 2024
- Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
- Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
- Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference